eli lilly and company retatrutide Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more: https://t.co/YZ6AWs9FqL Eli Lilly delays retatrutide weight

Unlike other weight-loss injections, retatrutide activates GLP-1, GIP, and glucagon receptors simultaneously, whereas typical injections target one or two of these receptors

First, the Protein Data Bank ( was used to download the SIRT1 crystal structure ( PDB code: 4ZZJ )

While standard autoimmune evaluation typically focuses on antibody panels and inflammatory markers that confirm the presence of autoimmune activity, functional assessment investigates the underlying factors driving immune dysregulation to develop more targeted therapeutic strategies

R., and Coimbra M

FDA has increasingly focused on escalating its enforcement activity against compounded GLP-1 drugs following US President Donald Trumps September 9, 2025, memorandum on prescription drug advertisements, which called on the FDA commissioner and the secretary of the US Department of Health and Human Services (HHS) to take actions to enforce prescription drug advertising laws and regulations